AKRON BIOTECH

Company Overview

Akron Biotech was established in 2006. Since then, the company has offered ancillary materials in the CGT industry. Its Closed System Solutions line of cGMP products, including cytokines, growth factors, nucleases, human plasma-derived products, media, and media supplements, are available in single-use, ready-to-use bags with weldable tubing to provide consistency and sterility assurance. Recombinant Human Interleukin-2 CSS, Human Serum Albumin 25% Solution CSS and Human AB Serum CSS converted from Octaplas, Pooled Plasma (Human), Xeno-Free, Virus Inactivated are CSS lines offered by the company. Based on customer requirements, the company provides customized recombinant proteins, mediums, and products for gene and cell therapy—all under cGMP. By collaborating with developers of advanced therapies, Akron helps meet unmet patient needs by offering essential materials and services at the scale, compliance level, and regulatory support required to propel novel treatments from discovery to commercialization.

Company's Business Segments

• Products : Cytokines, Growth Factors, Nucleases, Human Plasma Derived Products, Media and Media Supplements, Closed System Solutions (CSS) line of cGMP Products
• Services : Plasmid DNA and Endonucleases, Proteins, Media and Buffers, Transfection and Transduction Reagents